At eight o'clock in the evening, reporters from well-known media in the world gathered in the press conference hall of the Lido Hotel.
Due to numerous reports from the world's news media in the past two days, "probiotics", a special drug for treating cancer, have become familiar to people around the world. This has prompted media that have not dispatched reporters to urgently send column reporters to Fengjing City, China.
So the number of reporters attending the press conference this evening has more than doubled. Coupled with representatives from various medical institutions, pharmaceutical companies and sales companies, the press conference hall was already packed with people who were qualified to enter.
At five minutes past eight, all members of the World Health Organization expert team, the China Food and Drug Administration expert team, and the evaluation team composed of experts from world-renowned medical institutions arrived at the venue and took their seats in the front row.
Ms. Chen Qiuyu, spokesperson of "Xingkong Pharmaceutical", came to the podium.
"Hello, gentlemen and ladies!
After anxiously waiting, you have finally arrived at this news release. You are here mainly to hear the therapeutic effects of the Phase 1 clinical trial of 'Probiotics'. If I go on and on about something off-topic I will become everyone's public enemy. So let's get down to business.
Now I am announcing the therapeutic effect report of the first phase clinical trial of the new drug for treating cancer, 'Probiotics'.
A total of 98 patients with advanced cancer participated in this clinical trial. These 98 people all received a two-day intravenous infusion treatment of probiotics as planned, with two bottles of 5 million units of 0.5ML probiotics added to the infusion every day. After two days of treatment, the examination results of all patients are as follows:
Patient Smith is a senior reporter for CBS News. The location of the lesions before treatment: metastatic lesions in the rectum, liver, lungs, lymph nodes, etc., and the blood test indicators were...,...
After two days of treatment, the multifocal cancer tumors disappeared and became undetectable. The blood test indicators are...,...
After comprehensive examination and evaluation by an expert group composed of experts from the World Health Organization and China Food and Drug Administration, as well as experts appointed by well-known medical institutions around the world, all members unanimously agreed on the medical efficacy evaluation of patient Smith after treatment with 'probiotics' for 'healing'.
Patient Yamaguchi Yuo,…,…
…
All members unanimously agreed that the medical effect of the patient Yufu Yamaguchi's treatment with 'probiotics' was rated as 'recovered'.
…
Patient Liu Chengsheng,…
…
All members unanimously agreed that the medical efficacy of patient Liu Chengsheng after treatment with 'probiotics' was rated as 'cured'. "
When the medical appraisal reports of 98 patients all ended with "recovered".
The venue was already buzzing with excitement, and reporters began to use various advanced communication tools to convey this world-shaking news back to their respective news agencies.
When the news was reported to the newspaper, almost all the editors-in-chief of print media requested to print additional supplements urgently. They seemed to have a tacit understanding and printed the largest single line of characters on the first page: "Cancer is conquered", "Cure cancer is easier than curing a cold and only takes two days", etc. and other words like this.
Charlie King, a certain European TV media host who was doing a live broadcast, could no longer restrain his excitement and shouted during the live broadcast:
"Dear viewers, you should be as excited as I am now. Cancer, a terminal disease, has disappeared from our dictionary. What a great invention, what a great drug, and what a great inventor.
You can imagine that when you have cancer, you go to the hospital alone to get a shot, and then return to work to continue working.
But your boss is extremely dissatisfied with the fact that you are late for work even though you have such a minor illness. He points at you and curses you. If you are late for work because of such a big deal, your bonus will be deducted this month.
What a beautiful picture.
If Dr. Chen Ning, the inventor of 'probiotics' who is like 'God's gift to the world', cannot win this year's 'Nobel Prize in Medicine', then this award should disappear..."
Another host interjected: "Hey, this is not accurate. It should be about next year's Nobel Prize in Medicine, because the recommendation and review of this year's Nobel Prize has ended. It is impossible to win again. Because Dr. Chen Ning, the inventor of 'probiotics', has restarted the review process."
The host Charlie King shouted: "I still think that this year's Nobel Prize in medicine belongs to Dr. Chen Ning. Why can't this great invention impress the gentlemen sitting in the high-backed leather chairs? Let this rigid and rotten program go to hell..."
China Central Television News Channel "... Dr. Chen Ning, the great inventor who has benefited the world, has been engaged in the pharmaceutical industry for more than 30 years..., he saw the pain of cancer patients and their families and set his ambition to conquer this terminal disease... ,…"
The press conference was chaotic for more than 20 minutes, and Ms. Chen Qiuyu had no choice but to sit down and rest temporarily.
After the venue calmed down for a while, Ms. Chen Qiuyu stepped onto the stage again.
"Gentlemen and ladies, please be quiet. I will have important news to announce next. Please be quiet."
Ms. Chen Qiuyu waited for ten seconds, and people's attention returned to her again.
"With the request of the World Health Organization and the special approval of the China Food and Drug Administration, the Phase 2 and Phase 3 clinical trials of 'probiotics' will be conducted in conjunction with medical clinical applications.
In other words, 'probiotics' will be directly marketed in China from 8 o'clock today, and will directly enter clinical application and treatment in China.
When other countries can use 'prebiotics' in clinical applications, it still needs to be approved by the relevant departments of each country.
I know that the journalists below have a lot of questions to ask. Due to time constraints, we only have one hour of question and answer time. These experts and gentlemen sitting in the front row have not eaten after working all afternoon. I want them to One hour of patience is already the limit. Okay, now you can ask questions, which friend? "
As soon as Chen Qiuyu finished speaking, the reporters in the audience raised their hands. Chen Qiuyu pointed at the American reporter in the second row and said, "This gentleman."
"Hello, Ms. Chen, I am Tom, a reporter from the New York Times in the United States. What is the price of Ms. Chen's probiotics? What is your company's annual output? Also, under what conditions can your company export to other countries? ?"
"Dear reporters, since there are many reporters who want to ask questions, I hope that the reporters I called will only ask one question to give everyone a fair opportunity. Mr. Tom is the first reporter to ask questions, so I will answer his three questions. .
Although the selling price of 'probiotics' has not yet been specifically determined, the cost calculated based on the company's manufacturing cost calculations, of course, includes research and development costs. The ex-factory price of each 5 million unit of 0.5 ml medicine is 250,000 yuan in China. Overseas it is US$250,000.
The company currently has only one production line and limited production capacity. And because the probiotic culture process is extremely complex and cumbersome, increasing production cannot be achieved by relying on scale. Therefore, the annual output is only 400,000 tubes, which can be used to treat 100,000 people.
Regarding the conditions for exporting to foreign countries, I think there are two aspects. One is the issue of China's export restrictions.
This is a political issue between countries that everyone knows, and as a law-abiding company, there is nothing we can do. For example, the United States and the European Union have imposed export restrictions on high-tech products to China. And our company's 'probiotics' seem to be considered high-tech products. I don't know what restrictive policies the Chinese government has.
On the other hand, different countries have different clinical requirements for drugs, and the company does not have the ability to conduct clinical trials in every country that meet the requirements of that country. Therefore, we will not consider exporting to countries that require 'probiotics' to pass clinical trials in that country.
Therefore, as long as there are no obstacles in these two aspects and the company's output can meet the export requirements. Our company is happy to export to any country. "
Chen Qiuyu talked in detail and linked the high-tech product export restrictions and arms embargo policies adopted by the United States and the European Union towards China with the export of 'probiotics'. This is a huge favor to the Chinese government, which will give the Chinese government more room for maneuver when negotiating with the EU to lift the restrictive policy on China's high-tech products and arms embargo.
EU governments will also come under greater domestic pressure, and more and more people will support lifting the arms embargo and export restrictions on high-tech products against China.